Search research articles
Contact Us
Filters
Showing results (601-610 of 622) with videos related to
Page
of 63
Sort By:
The Lancet. Gastroenterology & Hepatology
|
December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Paula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom
Jonathan L Moore, Michael Green, Aida Santaolalla, et al.
Nature Communications
|
November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
Pietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
World Journal of Surgery
|
January 9, 2019
Unifying Children's Surgery and Anesthesia Stakeholders Across Institutions and Clinical Disciplines: Challenges and Solutions from Uganda
Phyllis Kisa, David F Grabski, Doruk Ozgediz, et al.
The Lancet. Digital Health
|
August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
Hannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
The Journal of Pathology
|
November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Benjamin R Challoner, Andrew Woolston, David Lau, et al.
JAMA Surgery
|
September 5, 2019
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Robert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, et al.
Health Technology Assessment (Winchester, England)
|
February 7, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
Paula Ghaneh, Robert Hanson, Andrew Titman, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 5, 2026
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials
Georgina A Keogh, Nina Šefčovičová, Tomio Arai, et al.
Science (New York, N.Y.)
|
February 24, 2018
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, et al.
Page
of 63
Search research articles
Search
Showing results (601-610 of 622) with videos related to
Sort By:
Page
of 63
The Lancet. Gastroenterology & Hepatology
|
December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Paula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom
Jonathan L Moore, Michael Green, Aida Santaolalla, et al.
Nature Communications
|
November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
Pietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
World Journal of Surgery
|
January 9, 2019
Unifying Children's Surgery and Anesthesia Stakeholders Across Institutions and Clinical Disciplines: Challenges and Solutions from Uganda
Phyllis Kisa, David F Grabski, Doruk Ozgediz, et al.
The Lancet. Digital Health
|
August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
Hannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
The Journal of Pathology
|
November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Benjamin R Challoner, Andrew Woolston, David Lau, et al.
JAMA Surgery
|
September 5, 2019
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Robert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, et al.
Health Technology Assessment (Winchester, England)
|
February 7, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
Paula Ghaneh, Robert Hanson, Andrew Titman, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 5, 2026
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials
Georgina A Keogh, Nina Šefčovičová, Tomio Arai, et al.
Science (New York, N.Y.)
|
February 24, 2018
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, et al.
Page
of 63